Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hypertonic Saline for Treatment of Pulmonary MAC Disease
NCT04921943Phase 4Recruiting
- Sponsor
- Oregon Health & Science University
- Start
- May 2021
- Primary completion
- Jan 2027
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 2
01
Overview
A Phase 4 trial of hypertonic saline in nontuberculous mycobacterial lung disease, sponsored by Oregon Health & Science University. Started May 2021; status: recruiting.
02
Drugs
hypertonic saline
03
Conditions
nontuberculous mycobacterial lung disease
Beyond the preview
Go deeper on NCT04921943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04921943.